Events
-
-
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
ASCO 2026: Phase 3 PEAK study could usher in new second-line therapy for GIST
-
ASCO 2026: Personalised vaccine boosts immune activity against brain cancer
-
ASCO 2026: GLP-1s may reduce metastatic progression of certain obesity-related cancers
-
ASCO 2026: Yoga may help cancer survivors sleep better and reduce anxiety, fatigue
-
-
Sharks’ low mutation rate cancer shield but a survival challenge
New international Monash University-led research has explained the reasons for and implications of low cancer…
Anti-anxiety drug may improve brain cancer survival chances
A new research study shows that cerebrospinal fluid reduces current treatment efficacy in brain cancer…
Researchers identify biology behind aggressive breast cancers in Black women
Researchers at Indiana University Melvin and Bren Simon Comprehensive Cancer Center, USA, are unlocking the…
Cancer deaths decline in US, with advances in prevention, detection and treatment
Jonathan M. Gerber, University of Massachusetts Medical School The American Cancer Society recently reported a drop in the overall cancer…
JOIN THE ONCOLOGY NETWORK
If you would like even more free news articles, access to our exclusive HCP only content including the latest podcasts from The Oncology Podcast and our Industry Partner Podcasts (including links to all papers and show notes), along with all our other resources, head over to The Oncology Network and sign up - FREE forever for HCPs only.